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Lack of requirement for Presenilin1 in Notch1 signaling
B.E. Berechid*, G. Thinakaran†, P.C. Wong‡, S.S. Sisodia† and J.S. Nye*§
Studies in invertebrates have indicated a functional
requirement for presenilin (PS) genes in the Notch
pathway [1–5]. One model of Notch signal transduction
suggests that proteolysis releases an activated Notch
fragment that migrates to the nucleus and regulates
gene transcription in concert with CBF1/Su(H)/lag1
(CSL) proteins [6–9]. Recent studies suggest that PS
genes control the proteolysis and nuclear access of the
Notch intracellular domain [3,4,10,11], offering a basis
for the functional interaction of PS and Notch genes
[12]. Here, we report that Notch1 signaling elicited by
the ligand Delta1 was quantitatively unchanged in PS1-
deficient primary embryonic fibroblasts (PEFs). Notch1
signals were measured by both the activation of the
hairy/enhancer of split (HES1) promoter and by the
antagonism of MyoD-induced muscle creatine kinase
(MCK) promoter activity. A membrane-tethered ligand-
independent Notch1 construct also showed full efficacy
in both assays, despite its presumed requirement for
cleavage. Although signaling through Notch1 persisted
in PS1-deficient cells, we found a marked reduction in
the appearance of a complex of a cleaved, intracellular
Notch fragment (NICD) and a CSL protein, as previously
reported [6,10]. These studies reveal that PS1 is not
required for ligand-dependent Notch signaling, and that
PS1 and PS2 may be redundant. Our data also suggest
that the identified NICD fragment may not be necessary
for Notch signal transduction [9].
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Results and discussion
In order to measure the effect of PS1 deficiency on ligand-
dependent and ligand-independent Notch signaling, we
established PEFs from PS1 heterozygous intercrosses [13]
(Figure 1). PS1–/– PEFs did not express PS1 but did
express PS2 mRNA and a mature, carboxy-terminal frag-
ment of PS2 protein at similar levels to those seen in PS1+/+
cultures. PEFs expressed Notch1 protein, as detected by
an antibody directed to its intracellular domain. Neither the
quantity of the 120 kDa intracellular domain, nor the small
amount of full-length protein (250 kDa) was significantly
altered by the absence of PS1 in these cells. Additionally,
the expression of Jagged1 mRNA, which encodes a ligand of
Notch proteins, was not altered in PS1-null cells compared
to control (Figure 1).
In mammalian cells, Notch signals induce the expression
of the HES1 gene and can antagonize MyoD-mediated
activation of muscle-specific promoters [14,15]. These
effects are thought to be accomplished by an association of
the intracellular domain of Notch with a CSL protein [9],
although a CSL-independent pathway may also have a
role in MyoD antagonism [16]. To test the role of PS1 in
Delta1-dependent HES1 activation [17], PS1+/+, PS1+/–
and PS1–/– cultures of PEFs were transiently transfected
with a HES1–luciferase (HES1–luc) reporter gene in the
presence or absence of exogenous Myc-tagged Notch1
(Notch1–Myc6) and then cultured with control or Delta1-
expressing QT6 quail cells (QT6-Delta1; Figure 2a–c).
QT6-Delta1 cells activated the HES1 promoter approxi-
mately 1.6-fold more than control QT6 cells in the
absence of exogenous Notch1 (Figure 2a, bars 1,2) but
activated it significantly more when Notch1–Myc6 was
cotransfected (Figure 2a, bars 3,4). In contrast, no effect of
QT6-Delta1 cells was observed when a mutant form of
the HES1 promoter containing a deletion of the CSL
binding sites, HES1∆AB [14], was used (Figure 2a, bars
5–8) indicating that Delta1 cells elicit a Notch-dependent
stimulation of the HES1 promoter that is mediated by
CSL binding sites. PEF cultures derived from PS1+/– and
PS1–/– littermate embryos also showed ligand-dependent
Notch1 activation of HES1 that was enhanced when
exogenous Notch1 was cotransfected and was dependent
on the presence of CSL binding sites (Figure 2b,c). The
magnitude of the ligand-induced activity was quantita-
tively similar in PS1+/+, PS1+/– and PS1–/– cultures. Thus,
the deficiency of PS1 did not significantly alter ligand-
induced activation of the HES1 promoter, indicating that
PS1 is not required in this assay of Notch signaling.
Next, we studied the requirement of PS1 for Delta1-
induced antagonism of MyoD by Notch1. Both Delta1
and Jagged1, two vertebrate ligands for Notch, have been
shown to trigger the ability of Notch1 to inhibit myogene-
sis [17,18]. We found that PS1+/+, PS1+/– and PS1–/– PEFs
could activate MCK–luciferase (MCK–luc) approximately
2.5-fold in the presence of MyoD when cultured with
QT6 cells (Figure 2d–f, bars 1,3). We then evaluated the
ability of these cells to undergo Delta1-induced inhibition
of MyoD by coculturing the PEFs with Delta1-expressing
QT6 cells. Whereas Delta1-QT6 cells had little effect on
basal MCK transcription compared to control QT6 cells,
Delta1-QT6 cells modestly repressed (5–20%) MyoD-
activated MCK transcription, and significantly repressed
(40–60%) MCK transcription in PEFs transfected with
both MyoD and Notch1–Myc6 (Fig 2d–f). Importantly,
and similar to the results of HES1 activation, the level of
MCK–luc inhibition was the same in PS1+/+, PS1+/– and
PS1–/– cultures, demonstrating that ligand-induced inhibi-
tion of MyoD by Notch1 does not require PS1.
The intracellular domain of Notch has access to the
nucleus [6–8] and a cleavage site was identified at Val1744
in this domain [6]. A fractional decline in signaling
occurred when Val1744 was mutated to amino acids that
diminished the cleavage of Notch1 at this site [6]. These
studies support a model in which cleavage and nuclear
translocation of the intracellular domain are essential for
signal transduction. Recent studies imply that presenilins
affect Notch signaling through a modulation of the pro-
cessing of Notch similar to the function of presenilins in
regulating amyloid precursor protein processing
[3,4,6–8,10–12]. To observe the proteolytic release of the
cleaved NICD protein, we studied wild-type and PS1-null
PEFs transfected with a membrane-tethered intracellular
domain construct of Notch1 (TM-Notch1IC–Myc6) and
performed co-immunoprecipitation experiments with
FLAG-tagged CSLRBP3 (CSLRBP3–FLAG; Figure 3). The
NICD fragment could not be detected by anti-Myc
immunoblotting in either the presence or the absence of
cotransfected CSLRBP3–FLAG (Figure 3, lanes 1–4). Fol-
lowing co-immunoprecipitation using an anti-FLAG anti-
body, however, a protein species the size of NICD was
observed in wild-type cells but not in PS1-null cells
(Figure 3, lanes 8–9). These data confirm that the
CSLRBP3–NICD complex is markedly depleted in PS1-
deficient cells [10]. 
Finally, we compared hemagglutinin (HA)-tagged mem-
brane-tethered and Myc-tagged non-membrane-tethered
activated forms of Notch1, HA–TM-Notch1IC [19] and
Notch1IC [20], respectively, in assays of Notch signaling in
PS1-deficient and control cells (Figure 4a). HA–TM-
Notch1IC activated the HES1 promoter 5–7-fold in PS1+/+
and PS1+/– fibroblasts. HA–TM-Notch1IC (Figure 4a) and
TM-Notch1IC–Myc6 (data not shown) also activated the
HES1 promoter in PS1-deficient PEFs. Similarly, Notch1IC
activated HES1 in all three genotypes (Figure 4a). A slightly
greater HES1 activation was observed in PS1-null cells than
PS1+/– and PS1+/+ cells with both Notch1 constructs. We
also measured the effect of PS1 deficiency on the ability of
the activated Notch1 to suppress myogenesis by measuring
the transactivation of an MCK–luc reporter gene by MyoD.
PEFs were transiently transfected with MCK–luc along with
MyoD and either HA–TM-Notch1IC (Figure 4b) or
Notch1IC (Figure 4c). Transfection of MyoD reproducibly
produced a 3–5-fold activation of MCK. HA–TM-Notch1IC
produced 20–60% inhibition of MyoD-activated MCK
expression over a range of DNA concentrations (Figure 4b).
Similarly, the range of Notch1IC inhibition varied from 30%
at the lowest DNA concentration to 73% at the highest
(Figure 4c). The inhibition of MyoD-induced MCK pro-
moter activity was equivalent in all three PS1 genotypes.
The absence of an effect of PS1 deficiency on activated
Notch constructs in these two assays implies that mem-
brane-tethered and non-membrane-tethered intracellular
Notch1 constructs in mammalian cells do not (as previously
observed in one study of Drosophila development) require
presenilins for their activity [4]. Additionally, the diminu-
tion of CSL-bound NICD in PS1-null cells observed above
did not correspond to any decline in Notch signals. 
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Figure 1
Characterization of primary embryo fibroblasts
(PEFs) derived from PS1+/+, PS1+/–, and
PS1–/– embryos. (a) PCR genotyping of PEFs
[13] showing wild-type (WT) and mutant
(mut) alleles. (b) Expression of cleaved PS1
protein in PEFs and a PS1-expressing N2a
neuroblastoma line (as a positive control).
(c) Expression of PS2 mRNA, with a γ-actin
control. (d) Expression of PS2 protein.
(e) Expression of Notch1 protein (using the
C20 antibody, Santa Cruz Biotechnologies).
FL, full-length Notch1; p120, Notch1
transmembrane–intracellular domain.
(f) Expression of mouse Jagged1 (mJag1)
mRNA with a γ-actin control. See
Supplementary material for additional
experimental details.
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These studies reveal that a deficiency of PS1 had no mea-
surable effect on Delta1-induced Notch1 signaling in
fibroblasts, as measured by both HES1 activation and
MyoD inhibition. Notch1 signaling also persisted in PS1-
null fibroblasts despite the virtual absence of an intracel-
lular fragment of Notch1 (NICD) bound to CSLRBP3,
which has, until now, been thought to be critical for Notch
signal transmission. Finally, PS1 deficiency did not impair
the activity of a membrane-tethered Notch1 intracellular
domain construct (HA–TM-Notch1IC), which presumably
requires cleavage for its activity. The redundancy of pre-
senilin genes is the most likely explanation for the persis-
tence of Notch signals in PS1-deficient cells. Similar to
what was observed in C. elegans, mice lacking both mam-
malian PS homologues display a phenotype that resem-
bles a deletion of key Notch pathway genes, more severe
than a deletion of either PS1 or PS2 alone [5,13,21–24].
This suggests that PS2 plays a compensatory role in Notch
signaling, and explains why we did not observe an impair-
ment of ligand-induced Notch1 activation in PS1-null
fibroblasts. In contrast, a recent study on neurite out-
growth and its control by Notch signals gives indirect evi-
dence of impaired Notch function in PS1-null neurons
[25]. However, we have observed no alteration of endoge-
nous neurite growth in PS1-deficient neuron cultures, and
these cultures also express PS2 (J. Palacino, B. Wolozin,
B.E.B. and J.S.N., unpublished observations).
The lack of the NICD fragment in PS1-deficient cells and
the preservation of Notch signaling observed here implies
that production of the NICD fragment is not, as previ-
ously suggested, essential for Notch signal transduction
[6,10,11]. Studies of transfected mammalian Notch1 pro-
teins have focused on a single cleavage of the intracellular
domain. In Drosophila, however, the endogenous intracel-
lular domain of Notch was shown to be cleaved in several
places [7,9,26] and the proteolytic products and their dis-
tribution within cells were altered in presenilin mutants
[3,4]. Our data showing signaling in the virtual absence of
the NICD fragment are consistent with models in which
Notch signals are transduced by more than one intracellu-
lar fragment of Notch, as well as models in which an
uncleaved portion of the intracellular Notch receptor acti-
vates CSL proteins, as previously proposed [9].
Supplementary material
Supplementary material including additional experimental details is
available at http://current-biology.com/supmat/supmatin.htm.
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Figure 3
Detection of the cleaved intracellular domain of Notch (NICD) in
PS1+/+ and PS1–/– fibroblasts. PEFs were transfected with TM-
Notch1IC–Myc6 with or without CSLRBP3–FLAG as indicated. Cell
extracts (lanes 1–5) and immunoprecipitates produced using an anti-
FLAG antibody (lanes 6–9) were immunoblotted with an anti-Myc
antibody (9E10) and compared with transfected NICD–Myc6 protein
[6] (lane 5). Full-length TM-Notch1IC–Myc6 (arrow) alone is seen in
extracts. Following immunoprecipitation, both the full length TM-
Notch1IC and NICD fragments were immunoprecipitated from PS1+/+
PEFs, but NICD was markedly reduced in PS1–/– PEFs.
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Figure 2
Delta1-dependent Notch signaling in control and PS1-null fibroblasts.
(a–c) HES1 activation  and (d–f) MyoD antagonism were tested in
(a,d) PS1+/+, (b,e) PS1+/– and (c,f) PS1–/– cultures grown on control
QT6 or Delta1-expressing QT6 cells (see Supplementary material for
experimental details). (a–c) Cells were transfected with 500 ng
HES1–luc (lanes 1–4) or 500 ng HES1∆AB–luc [14] (lanes 5–8)
along with Notch1–Myc6 (1 µg) as indicated. (d–f) Cells were
transfected with 500 ng MCK–luc (lanes 1–6) along with 500 ng the
activator MyoD (lanes 3–6). The mean luciferase activation relative to
lane 1 was calculated, and the significance of the level of activation
with QT6 cells compared to that with QT6-Delta1 cells was assessed
with a two-tailed Student’s t test. *, p < 0.05; **, p < 0.01.
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Ligand-independent Notch signaling in PS1+/+, PS1+/– and PS1–/–
fibroblasts. (a) HES1 activation. PEFs were transfected with
HES1–luc (200 ng) with either vector control, HA–TM-Notch1IC or
Notch1IC. The level of HES1 activation by HA–TM-Notch1IC and
Notch1IC was significantly higher than control in cells of each of the
three genotypes, by a two-tailed Student’s t test (*, p < 0.05; **, 
p < 0.01; ***, p < 0.001). The effect of genotype was also significant
by one-way analysis of variance (ANOVA; p = 0.016). (b,c) Inhibition
of MCK activation. PEFs were transfected with MCK–luc (500 ng)
along with MyoD (500 ng). In addition, increasing amounts of
(b) HA–TM-Notch1IC or (c) Notch1IC were cotransfected. Maximal
activation of MCK–luc is achieved in the absence of added Notch1.
Percentage maximal activation of MCK–luc is plotted. No effect of
genotype was observed by ANOVA.
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Supplementary materials and methods
Primary fibroblasts
Embryos from PS1 heterozygous matings were harvested into individ-
ual flasks on embryonic day E14.5 [S1]. After the head and organs
were removed the body cavity was dispersed in DMEM (high glucose),
10% FBS, 2 mM L-glutamine, 1% penicillin–streptomycin (Gibco BRL).
For each cell line, PCR genotyping was performed on genomic DNA
extracted from corresponding organs. PCR amplification of endoge-
nous and targeted PS1 alleles produce fragments of 500 bp and
370 bp, respectively. 
Immunoblots and antibodies
Cells were extracted in SDS sample buffer (50 mM Tris–HCl pH 6.8,
10% glycerol, 2% SDS) in the presence of protease inhibitors: PMSF
(0.1 mM), antipain (10 µg/ml), pepstatin A (10 µg/ml), soybean trypsin
inhibitor (10 µg/ml) and benzamidine (0.044%). Extracts were sepa-
rated by SDS–PAGE and transferred to nitrocellulose. Polyclonal anti-
bodies against the carboxy-terminal loop domains of human PS1 [S2]
and human PS2 [S3] were used to detect PS expression using 30 µg
of protein. A polyclonal antibody against the carboxy-terminal domain of
mouse Notch1 (mNotch1; C20, Santa Cruz Biotechnologies) was
used to detect Notch1 expression using 10 µg of protein. Myc-tagged
Notch1 constructs were detected with an anti-Myc monoclonal anti-
body (9E10). Bound antibodies were detected with a chemilumines-
cent substrate (Pierce).
Northern blot hybridization
RNA was prepared from primary fibroblasts using TRIZOL Reagent
(Gibco BRL). Total RNA (10 µg) was run on a 1.2% agarose gel con-
taining 5 mM methylmercury hydroxide and was transferred to nylon by
electroblotting. 32P-labeled probes were prepared using the PrimeIt II
kit (Stratagene). Hybridization was performed in Church buffer
(1% BSA, 7% SDS, 0.5 M NaH2PO4 pH 7.0, 1 mM EDTA, 100 µg/ml
salmon sperm DNA) at 65°C for 16 h. Jagged1 cDNA was a gift from
Genentech and mPS2 cDNA was a gift from Luciano D’Adamio. A
human γ-actin probe was used as a loading control [S4].
DNA constructs
Notch1–Myc6 encodes mouse Notch1 (amino acids 1–2185) with a
carboxy-terminal hexameric Myc tag [S5]. Notch1IC contains the intra-
cellular domain of mNotch1 with an amino terminal Myc epitope [S6].
HA–TM-Notch1IC contains the transmembrane and intracellular
domains of mNotch1 with an amino-terminal hemagglutinin (HA) tag
and a carboxy-terminal Myc tag [S7]. TM-Notch1IC–Myc6 (also called
mNotch∆E) contains the transmembrane and intracellular domains of
Notch1 terminating at amino acid 2185 (at the XhoI site), followed by a
carboxy-terminal hexameric Myc epitope [S7]. NICD–Myc6 [S5] and
MyoD were kind gifts of R. Kopan. CSLRBP3–FLAG, HES1–luc and
HES1∆AB–luc were gifts from Alain Israël. HES1–luc contains
nucleotides –194 to +160 of the HES1 promoter cloned upstream of
the luciferase gene [S8]. HES1∆AB–luc contains a deletion of both
CSL binding sites in the HES1 promoter [S8]. MCK–luc contains
3.3 kb of the promoter sequence of MCK [S9] cloned upstream of the
luciferase gene in the pGL2-basic vector (Promega).
Transfection and luciferase assays
PEFs were plated in six-well dishes at a density of 2 × 105 cells per
well and transfected the following day with Lipofectamine Plus (Gibco
BRL). The amount of DNA added to each well was equalized by the
addition of a control plasmid, pCDNA3. Cells were harvested 48 h post
transfection and luciferase activity was measured using a luminometer.
To ensure equivalent transfection between lines a control reporter gene
(thymidine kinase–renilla luciferase) was included with each experi-
ment. For coculture assays [S10], QT6 or QT6-Delta1 cells (a kind gift
of O. Pourquié) were plated at a density of 1 × 106 cells per well 24 h
after transfection and harvested 24 h later for luciferase measurements.
The data presented in Figures 2,4 represent the mean of 3–5 indepen-
dent experiments, each performed in triplicate.
Immunoprecipitation
PEFs were plated at a density of 3 × 106 cells per plate in a 10 cm
plate and transfected the following day. Cells were harvested 48 h after
transfection in cold 0.25% n-dodecyl α-D-maltoside (Sigma) in PBS
containing protease inhibitors (see Immunoblots and antibodies) and
lysates were subjected to centrifugation at 10,000 × g for 10 min to
remove cellular debris. Lysates were precleared by the addition of puri-
fied immunoglobulin G1 followed by incubation with protein G beads
(UltraLink, Pierce). Precleared lysates were then incubated with 2 µg
anti-FLAG antibody (Sigma) per 200 µg protein on ice for 45 min, and
immune complexes were pulled down with protein G beads after an
additional 30 min incubation at 4°C. A very small amount of uncleaved
TM-Notch1IC is non-specifically precipitated in the absence of cotrans-
fected CSLRBP3–FLAG (see Figure 3).
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